Related Experiment Videos

Concerns of a pediatric hospital's P & T Committee: quality care emphasized over cost considerations

T Reiley1, H Wedemeyer

  • 1Children's Hospital, Denver, CO 80218.

Hospital Formulary
|October 1, 1990
PubMed

Insights

Pediatric drug data is lacking for many adult-approved medications. Children's Hospital of Denver is addressing this by conducting drug evaluations and collaborating with other children's hospitals to improve pediatric patient care.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Development

Background:

  • The P&T Committee at Children's Hospital of Denver faces challenges due to limited pharmacologic and pharmacokinetic data for adult drugs not approved for pediatric use.
  • This data gap hinders the safe and effective prescription of medications for children.

Discussion:

  • The hospital's P&T Committee will conduct drug usage evaluations to gather essential data.
  • A cooperative data-exchange venture with other children's hospitals in the U.S. and Canada is being established.
  • Priorities include quality of care and formulation palatability, alongside cost considerations.

Key Insights:

  • Proactive data acquisition is crucial for expanding the safe use of medications in pediatric populations.
  • Inter-institutional collaboration can accelerate the generation of vital pediatric drug information.
  • Addressing formulation and taste is essential for adherence and treatment success in children.

Outlook:

  • This initiative aims to enhance evidence-based prescribing for pediatric patients.
  • The collaborative model can serve as a template for other pediatric centers.
  • Improved data will support regulatory submissions for pediatric drug indications.

Related Concept Videos